MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2025 International Congress

    Metabolomic breath landscape analysis unravels lipid biomarker candidates in patients with monogenic and idiopathic Parkinson’s disease

    M. Malik, N. Brüggemann, T. Usnich, M. Borsche, T. Demetrowitsch, K. Schwarz, P. Bauer, K. Lohmann, C. Klein, T. Kunze (Luebeck, Germany)

    Objective: We propose an untargeted metabolomics approach using exhaled breath analysis to (1) characterize the non-volatile metabolomic breath signature of Parkinson’s disease (PD) patients with…
  • 2025 International Congress

    Quantitative Digitography and Home Diaries for PD Motor State Evaluation

    K. Daley, A. Negi, S. Karjagi, A. Abay, P. Acharyya, P. Schmiedmayer, K. Wilkins, H. Bronte-Stewart (Palo Alto, USA)

    Objective: Assess the feasibility of people with Parkinson’s (PwP) performing 30 seconds of repetitive alternating finger presses using Quantitative Digitography (QDG) technology every 30 minutes…
  • 2025 International Congress

    CSF Mitochondrial DNA Indicates Body Composition and Energy Metabolism in Parkinson’s Disease.

    Y. Mizutani, T. Nakai, Y. Maeda, R. Ohdake, R. Nagao, S. Shima, K. Kawabata, A. Ueda, M. Ito, H. Watanabe (Toyoake, Japan)

    Objective: This study aimed to elucidate the associations between cerebrospinal fluid (CSF) cell-free mitochondrial DNA (cf-mtDNA) levels and body composition, nutritional status, and metabolic biomarkers…
  • 2025 International Congress

    Characterization of DBS-induced Speech Improvements in a German PD Cohort

    G. Brandt, K. Simon, T. Dembek, M. Barbe, T. Thies (Cologne, Germany)

    Objective: To investigate speech changes induced by subthalamic deep brain stimulation (DBS) in persons with Parkinson’s disease (pwPD). Background: Dysarthria is a common debilitating motor…
  • 2025 International Congress

    Digital measurement of ocular microtremor in Parkinson’s Disease: Analytical and clinical validation

    L. Graham, R. Vitorio, P. Tait, R. Walker, A. Godfrey, R. Morris, S. Stuart (Newcastle-upon-Tyne, United Kingdom)

    Objective: This pilot study examined the analytical and clinical validation of OMT measurement via the iTremor ONE device in PwPD. Background: Ocular microtremor (OMT) is…
  • 2025 International Congress

    Personality Traits and Neuropsychiatric Assessment in De Novo, Clinically Established Body-First and Brain-First Parkinson’s Disease

    P. Antenucci, M. Sensi, V. Resta, L. Spanedda, D. Zecchinato, G. Linzalone, A. Gozzi, L. Zerbinati (Ferrara, Italy)

    Objective: To assess and compare personality profiles and psychiatric symptoms in de-novo clinically-established body-first and brain-first PD. Background: Body-first and brain-first have recently been proposed…
  • 2025 International Congress

    Exploring Uncertainties and Fears of People with Parkinson Disease

    P. Gandhi, E. Trahair, D. Steiger, R. Rapoport, L. Chahine, C. Marras, S. Mantri (Edmonton, Canada)

    Objective: To assess the burden of uncertainties, hopes, and fears of people with Parkinson disease (PwP). Background: Parkinson disease (PD) is associated with significant psychosocial…
  • 2025 International Congress

    Neurophysiological research on inhibitory processes in Parkinson’s disease

    S. Parmigiani, K. Shultz, N. Swann, . , . (Eugene, USA)

    Objective: To explore neural mechanisms of inhibitory control, specifically differentiating reactive from prepared inhibitory processes, by synthesizing recent intracranial EEG (iEEG) studies and neurophysiological research…
  • 2025 International Congress

    Episodic Simulation in Parkinson’s Disease (PD)

    J. Decker, N. Hantke, E. Leonard (Portland, USA)

    Objective: Characterize episodic simulation capabilities in non-depressed, non-amnestic patients with PD compared to healthy controls using autobiographical interviewing techniques. Background: Cognitive decline in PD occurs…
  • 2025 International Congress

    Orthostatic Hypotension and Acute Cognitive Dysfunction in Parkinson’s Disease: Insights from fNIRS

    K. Longardner, P. Reddy, M. Skipworth, D. Salmon, K. Izzetoglu, I. Litvan (La Jolla, USA)

    Objective: To define cerebral oxygenation changes during positional cognitive testing in Parkinson’s disease (PD), comparing those with orthostatic hypotension (OH+) to those without (OH-). Background:…
  • « Previous Page
  • 1
  • …
  • 141
  • 142
  • 143
  • 144
  • 145
  • …
  • 181
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley